B细胞在瘤发生和免疫治疗中的作用
Guoping Yin1, Lingna Qi1, Na Kang2,3
1Department of Otorhinolaryngology-Head and Neck Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China.
Immune network
|March 9, 2026
概括
在癌症免疫疗法中,B细胞发挥着双重作用,在瘤微环境 (TME) 中表现出抗瘤和亲瘤效应. 了解这些复杂的功能对于开发向的B细胞疗法至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 越来越多的B细胞因其在各种固体瘤的瘤微环境 (TME) 中显著的透和功能影响而得到认可.
- 它们在瘤进展和免疫反应调节中的作用在历史上一直被低估.
研究的目的:
- 系统地审查B细胞在瘤发育中的双重调节机制.
- 分析影响B细胞功能和分化的关键因素.
- 探索向B细胞疗法在癌症免疫治疗中的临床前景.
主要方法:
- 文献综述和对TME中B细胞现有研究的系统分析.
- 检查B细胞介导的抗瘤和前瘤效应.
- 分析影响B细胞功能的因素.
主要成果:
- B细胞具有双重作用:通过三级淋巴体结构促进抗瘤免疫力,抗体依赖作用和T细胞激活,同时通过免疫抑制因素和免疫检查点抑制免疫力.
- 影响B细胞分化和功能的因素仍然不完全理解.
结论:
- B细胞是癌症免疫的关键参与者,它们既起到促进和抑制瘤生长的作用.
- 向B细胞为新型癌症免疫疗法提供了一个有希望的途径,因为它们对TME产生重大影响.
- 进一步阐明B细胞调节机制对于精确,有针对性的治疗策略至关重要.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
B Cell Activation and Differentiation
17.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.6K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cells of the Adaptive Immune Response
9.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.8K
T Cell Activation and Clonal Selection
16.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.9K
T Cell Types and Functions
3.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K


